Inspire Medical Systems (INSP) Return on Capital Employed (2018 - 2026)

Inspire Medical Systems (INSP) has 9 years of Return on Capital Employed data on file, last reported at 6.26% in Q1 2026.

• For the quarter ending Q1 2026, Return on Capital Employed fell 80.0% year-over-year to 6.26%; the trailing twelve-month figure through Mar 2026 stood at 6.26% (down 80.0% YoY), and the FY2025 full-year result was 6.69%, up 117.0% from the prior year.
• Return on Capital Employed slipped to 6.26% in Q1 2026, from 6.69% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.05% in Q1 2025 to a low of 17.08% in Q2 2022.
• A 5-year average of 3.67% and a median of 5.91% in 2024 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed surged 1296 bps in 2025 and tumbled 80 bps in 2026, its largest moves.
• Tracing INSP's Return on Capital Employed over 5 years: stood at 9.81% in 2022, then grew by 29 bps to 6.94% in 2023, then soared by 173 bps to 5.06% in 2024, then jumped by 32 bps to 6.69% in 2025, then retreated by 6 bps to 6.26% in 2026.
• Business Quant data shows INSP's Return on Capital Employed at 6.26% in Q1 2026, 6.69% in Q4 2025, and 5.29% in Q3 2025.